0
     

Report Added
Report already added
Opioid Induced Constipation (OIC) Drugs Market - Global Outlook and Forecast 2022-2028

Opioid Induced Constipation (OIC) Drugs Market - Global Outlook and Forecast 2022-2028

This report contains market size and forecasts of Opioid Induced Constipation (OIC) Drugs in global, including the following market information:

Global Opioid Induced Constipation (OIC) Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Opioid Induced Constipation (OIC) Drugs Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Opioid Induced Constipation (OIC) Drugs companies in 2021 (%)
The global Opioid Induced Constipation (OIC) Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Lubiprostone Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Opioid Induced Constipation (OIC) Drugs include Ironwood Pharmaceuticals Inc, Daiichi Sankyo Co Ltd, Pfizer, Progenics Pharmaceuticals Inc, Shionogi & Co., Ltd, Allergan Plc, Nektar Therapeutics, Purdue Pharma and S.L.A. Pharma AG, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Opioid Induced Constipation (OIC) Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:
Global Opioid Induced Constipation (OIC) Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Opioid Induced Constipation (OIC) Drugs Market Segment Percentages, by Type, 2021 (%)
Lubiprostone
Methyl Naltrexone Bromide
Naldemedine
Alvimopan
Others
Global Opioid Induced Constipation (OIC) Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Opioid Induced Constipation (OIC) Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Opioid Induced Constipation (OIC) Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Opioid Induced Constipation (OIC) Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Opioid Induced Constipation (OIC) Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Opioid Induced Constipation (OIC) Drugs revenues share in global market, 2021 (%)
Key companies Opioid Induced Constipation (OIC) Drugs sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Opioid Induced Constipation (OIC) Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Ironwood Pharmaceuticals Inc
Daiichi Sankyo Co Ltd
Pfizer
Progenics Pharmaceuticals Inc
Shionogi & Co., Ltd
Allergan Plc
Nektar Therapeutics
Purdue Pharma
S.L.A. Pharma AG
Mundipharma International Limited
Ono Pharmaceutical Co., Ltd
Takeda Pharmaceutical Company Limited
Theravance Biopharma Inc
Bausch Health
Cosmo Pharmaceuticals SA
Daewoong Pharmaceutical
C.B. Fleet Company
Sucampo Pharmaceuticals
Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Opioid Induced Constipation (OIC) Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Opioid Induced Constipation (OIC) Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Opioid Induced Constipation (OIC) Drugs Overall Market Size
2.1 Global Opioid Induced Constipation (OIC) Drugs Market Size: 2021 VS 2028
2.2 Global Opioid Induced Constipation (OIC) Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Opioid Induced Constipation (OIC) Drugs Sales: 2017-2028
3 Company Landscape
3.1 Top Opioid Induced Constipation (OIC) Drugs Players in Global Market
3.2 Top Global Opioid Induced Constipation (OIC) Drugs Companies Ranked by Revenue
3.3 Global Opioid Induced Constipation (OIC) Drugs Revenue by Companies
3.4 Global Opioid Induced Constipation (OIC) Drugs Sales by Companies
3.5 Global Opioid Induced Constipation (OIC) Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Opioid Induced Constipation (OIC) Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Opioid Induced Constipation (OIC) Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Opioid Induced Constipation (OIC) Drugs Players in Global Market
3.8.1 List of Global Tier 1 Opioid Induced Constipation (OIC) Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Opioid Induced Constipation (OIC) Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Opioid Induced Constipation (OIC) Drugs Market Size Markets, 2021 & 2028
4.1.2 Lubiprostone
4.1.3 Methyl Naltrexone Bromide
4.1.4 Naldemedine
4.1.5 Alvimopan
4.1.6 Others
4.2 By Type - Global Opioid Induced Constipation (OIC) Drugs Revenue & Forecasts
4.2.1 By Type - Global Opioid Induced Constipation (OIC) Drugs Revenue, 2017-2022
4.2.2 By Type - Global Opioid Induced Constipation (OIC) Drugs Revenue, 2023-2028
4.2.3 By Type - Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Opioid Induced Constipation (OIC) Drugs Sales & Forecasts
4.3.1 By Type - Global Opioid Induced Constipation (OIC) Drugs Sales, 2017-2022
4.3.2 By Type - Global Opioid Induced Constipation (OIC) Drugs Sales, 2023-2028
4.3.3 By Type - Global Opioid Induced Constipation (OIC) Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Opioid Induced Constipation (OIC) Drugs Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Opioid Induced Constipation (OIC) Drugs Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Opioid Induced Constipation (OIC) Drugs Revenue & Forecasts
5.2.1 By Application - Global Opioid Induced Constipation (OIC) Drugs Revenue, 2017-2022
5.2.2 By Application - Global Opioid Induced Constipation (OIC) Drugs Revenue, 2023-2028
5.2.3 By Application - Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Opioid Induced Constipation (OIC) Drugs Sales & Forecasts
5.3.1 By Application - Global Opioid Induced Constipation (OIC) Drugs Sales, 2017-2022
5.3.2 By Application - Global Opioid Induced Constipation (OIC) Drugs Sales, 2023-2028
5.3.3 By Application - Global Opioid Induced Constipation (OIC) Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Opioid Induced Constipation (OIC) Drugs Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Opioid Induced Constipation (OIC) Drugs Market Size, 2021 & 2028
6.2 By Region - Global Opioid Induced Constipation (OIC) Drugs Revenue & Forecasts
6.2.1 By Region - Global Opioid Induced Constipation (OIC) Drugs Revenue, 2017-2022
6.2.2 By Region - Global Opioid Induced Constipation (OIC) Drugs Revenue, 2023-2028
6.2.3 By Region - Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Opioid Induced Constipation (OIC) Drugs Sales & Forecasts
6.3.1 By Region - Global Opioid Induced Constipation (OIC) Drugs Sales, 2017-2022
6.3.2 By Region - Global Opioid Induced Constipation (OIC) Drugs Sales, 2023-2028
6.3.3 By Region - Global Opioid Induced Constipation (OIC) Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Opioid Induced Constipation (OIC) Drugs Revenue, 2017-2028
6.4.2 By Country - North America Opioid Induced Constipation (OIC) Drugs Sales, 2017-2028
6.4.3 US Opioid Induced Constipation (OIC) Drugs Market Size, 2017-2028
6.4.4 Canada Opioid Induced Constipation (OIC) Drugs Market Size, 2017-2028
6.4.5 Mexico Opioid Induced Constipation (OIC) Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Opioid Induced Constipation (OIC) Drugs Revenue, 2017-2028
6.5.2 By Country - Europe Opioid Induced Constipation (OIC) Drugs Sales, 2017-2028
6.5.3 Germany Opioid Induced Constipation (OIC) Drugs Market Size, 2017-2028
6.5.4 France Opioid Induced Constipation (OIC) Drugs Market Size, 2017-2028
6.5.5 U.K. Opioid Induced Constipation (OIC) Drugs Market Size, 2017-2028
6.5.6 Italy Opioid Induced Constipation (OIC) Drugs Market Size, 2017-2028
6.5.7 Russia Opioid Induced Constipation (OIC) Drugs Market Size, 2017-2028
6.5.8 Nordic Countries Opioid Induced Constipation (OIC) Drugs Market Size, 2017-2028
6.5.9 Benelux Opioid Induced Constipation (OIC) Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Opioid Induced Constipation (OIC) Drugs Revenue, 2017-2028
6.6.2 By Region - Asia Opioid Induced Constipation (OIC) Drugs Sales, 2017-2028
6.6.3 China Opioid Induced Constipation (OIC) Drugs Market Size, 2017-2028
6.6.4 Japan Opioid Induced Constipation (OIC) Drugs Market Size, 2017-2028
6.6.5 South Korea Opioid Induced Constipation (OIC) Drugs Market Size, 2017-2028
6.6.6 Southeast Asia Opioid Induced Constipation (OIC) Drugs Market Size, 2017-2028
6.6.7 India Opioid Induced Constipation (OIC) Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Opioid Induced Constipation (OIC) Drugs Revenue, 2017-2028
6.7.2 By Country - South America Opioid Induced Constipation (OIC) Drugs Sales, 2017-2028
6.7.3 Brazil Opioid Induced Constipation (OIC) Drugs Market Size, 2017-2028
6.7.4 Argentina Opioid Induced Constipation (OIC) Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Opioid Induced Constipation (OIC) Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales, 2017-2028
6.8.3 Turkey Opioid Induced Constipation (OIC) Drugs Market Size, 2017-2028
6.8.4 Israel Opioid Induced Constipation (OIC) Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia Opioid Induced Constipation (OIC) Drugs Market Size, 2017-2028
6.8.6 UAE Opioid Induced Constipation (OIC) Drugs Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Ironwood Pharmaceuticals Inc
7.1.1 Ironwood Pharmaceuticals Inc Corporate Summary
7.1.2 Ironwood Pharmaceuticals Inc Business Overview
7.1.3 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Major Product Offerings
7.1.4 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales and Revenue in Global (2017-2022)
7.1.5 Ironwood Pharmaceuticals Inc Key News
7.2 Daiichi Sankyo Co Ltd
7.2.1 Daiichi Sankyo Co Ltd Corporate Summary
7.2.2 Daiichi Sankyo Co Ltd Business Overview
7.2.3 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Major Product Offerings
7.2.4 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales and Revenue in Global (2017-2022)
7.2.5 Daiichi Sankyo Co Ltd Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Opioid Induced Constipation (OIC) Drugs Major Product Offerings
7.3.4 Pfizer Opioid Induced Constipation (OIC) Drugs Sales and Revenue in Global (2017-2022)
7.3.5 Pfizer Key News
7.4 Progenics Pharmaceuticals Inc
7.4.1 Progenics Pharmaceuticals Inc Corporate Summary
7.4.2 Progenics Pharmaceuticals Inc Business Overview
7.4.3 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Major Product Offerings
7.4.4 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales and Revenue in Global (2017-2022)
7.4.5 Progenics Pharmaceuticals Inc Key News
7.5 Shionogi & Co., Ltd
7.5.1 Shionogi & Co., Ltd Corporate Summary
7.5.2 Shionogi & Co., Ltd Business Overview
7.5.3 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Major Product Offerings
7.5.4 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales and Revenue in Global (2017-2022)
7.5.5 Shionogi & Co., Ltd Key News
7.6 Allergan Plc
7.6.1 Allergan Plc Corporate Summary
7.6.2 Allergan Plc Business Overview
7.6.3 Allergan Plc Opioid Induced Constipation (OIC) Drugs Major Product Offerings
7.6.4 Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales and Revenue in Global (2017-2022)
7.6.5 Allergan Plc Key News
7.7 Nektar Therapeutics
7.7.1 Nektar Therapeutics Corporate Summary
7.7.2 Nektar Therapeutics Business Overview
7.7.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Major Product Offerings
7.7.4 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales and Revenue in Global (2017-2022)
7.7.5 Nektar Therapeutics Key News
7.8 Purdue Pharma
7.8.1 Purdue Pharma Corporate Summary
7.8.2 Purdue Pharma Business Overview
7.8.3 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Major Product Offerings
7.8.4 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales and Revenue in Global (2017-2022)
7.8.5 Purdue Pharma Key News
7.9 S.L.A. Pharma AG
7.9.1 S.L.A. Pharma AG Corporate Summary
7.9.2 S.L.A. Pharma AG Business Overview
7.9.3 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Major Product Offerings
7.9.4 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales and Revenue in Global (2017-2022)
7.9.5 S.L.A. Pharma AG Key News
7.10 Mundipharma International Limited
7.10.1 Mundipharma International Limited Corporate Summary
7.10.2 Mundipharma International Limited Business Overview
7.10.3 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Major Product Offerings
7.10.4 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales and Revenue in Global (2017-2022)
7.10.5 Mundipharma International Limited Key News
7.11 Ono Pharmaceutical Co., Ltd
7.11.1 Ono Pharmaceutical Co., Ltd Corporate Summary
7.11.2 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Business Overview
7.11.3 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Major Product Offerings
7.11.4 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales and Revenue in Global (2017-2022)
7.11.5 Ono Pharmaceutical Co., Ltd Key News
7.12 Takeda Pharmaceutical Company Limited
7.12.1 Takeda Pharmaceutical Company Limited Corporate Summary
7.12.2 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Business Overview
7.12.3 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Major Product Offerings
7.12.4 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Sales and Revenue in Global (2017-2022)
7.12.5 Takeda Pharmaceutical Company Limited Key News
7.13 Theravance Biopharma Inc
7.13.1 Theravance Biopharma Inc Corporate Summary
7.13.2 Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Business Overview
7.13.3 Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Major Product Offerings
7.13.4 Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Sales and Revenue in Global (2017-2022)
7.13.5 Theravance Biopharma Inc Key News
7.14 Bausch Health
7.14.1 Bausch Health Corporate Summary
7.14.2 Bausch Health Business Overview
7.14.3 Bausch Health Opioid Induced Constipation (OIC) Drugs Major Product Offerings
7.14.4 Bausch Health Opioid Induced Constipation (OIC) Drugs Sales and Revenue in Global (2017-2022)
7.14.5 Bausch Health Key News
7.15 Cosmo Pharmaceuticals SA
7.15.1 Cosmo Pharmaceuticals SA Corporate Summary
7.15.2 Cosmo Pharmaceuticals SA Business Overview
7.15.3 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Major Product Offerings
7.15.4 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Sales and Revenue in Global (2017-2022)
7.15.5 Cosmo Pharmaceuticals SA Key News
7.16 Daewoong Pharmaceutical
7.16.1 Daewoong Pharmaceutical Corporate Summary
7.16.2 Daewoong Pharmaceutical Business Overview
7.16.3 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Major Product Offerings
7.16.4 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Sales and Revenue in Global (2017-2022)
7.16.5 Daewoong Pharmaceutical Key News
7.17 C.B. Fleet Company
7.17.1 C.B. Fleet Company Corporate Summary
7.17.2 C.B. Fleet Company Business Overview
7.17.3 C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Major Product Offerings
7.17.4 C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Sales and Revenue in Global (2017-2022)
7.17.5 C.B. Fleet Company Key News
7.18 Sucampo Pharmaceuticals
7.18.1 Sucampo Pharmaceuticals Corporate Summary
7.18.2 Sucampo Pharmaceuticals Business Overview
7.18.3 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Major Product Offerings
7.18.4 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Sales and Revenue in Global (2017-2022)
7.18.5 Sucampo Pharmaceuticals Key News
8 Global Opioid Induced Constipation (OIC) Drugs Production Capacity, Analysis
8.1 Global Opioid Induced Constipation (OIC) Drugs Production Capacity, 2017-2028
8.2 Opioid Induced Constipation (OIC) Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Opioid Induced Constipation (OIC) Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Opioid Induced Constipation (OIC) Drugs Supply Chain Analysis
10.1 Opioid Induced Constipation (OIC) Drugs Industry Value Chain
10.2 Opioid Induced Constipation (OIC) Drugs Upstream Market
10.3 Opioid Induced Constipation (OIC) Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Opioid Induced Constipation (OIC) Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Opioid Induced Constipation (OIC) Drugs in Global Market
Table 2. Top Opioid Induced Constipation (OIC) Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Opioid Induced Constipation (OIC) Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Opioid Induced Constipation (OIC) Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Opioid Induced Constipation (OIC) Drugs Sales by Companies, (K Pcs), 2017-2022
Table 6. Global Opioid Induced Constipation (OIC) Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Opioid Induced Constipation (OIC) Drugs Price (2017-2022) & (USD/Pcs)
Table 8. Global Manufacturers Opioid Induced Constipation (OIC) Drugs Product Type
Table 9. List of Global Tier 1 Opioid Induced Constipation (OIC) Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Opioid Induced Constipation (OIC) Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Opioid Induced Constipation (OIC) Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Opioid Induced Constipation (OIC) Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Opioid Induced Constipation (OIC) Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), 2017-2022
Table 15. By Type - Global Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), 2023-2028
Table 16. By Application – Global Opioid Induced Constipation (OIC) Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Opioid Induced Constipation (OIC) Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Opioid Induced Constipation (OIC) Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), 2017-2022
Table 20. By Application - Global Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), 2023-2028
Table 21. By Region – Global Opioid Induced Constipation (OIC) Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Opioid Induced Constipation (OIC) Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Opioid Induced Constipation (OIC) Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), 2017-2022
Table 25. By Region - Global Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), 2023-2028
Table 26. By Country - North America Opioid Induced Constipation (OIC) Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Opioid Induced Constipation (OIC) Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Opioid Induced Constipation (OIC) Drugs Sales, (K Pcs), 2017-2022
Table 29. By Country - North America Opioid Induced Constipation (OIC) Drugs Sales, (K Pcs), 2023-2028
Table 30. By Country - Europe Opioid Induced Constipation (OIC) Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Opioid Induced Constipation (OIC) Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Opioid Induced Constipation (OIC) Drugs Sales, (K Pcs), 2017-2022
Table 33. By Country - Europe Opioid Induced Constipation (OIC) Drugs Sales, (K Pcs), 2023-2028
Table 34. By Region - Asia Opioid Induced Constipation (OIC) Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Opioid Induced Constipation (OIC) Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Opioid Induced Constipation (OIC) Drugs Sales, (K Pcs), 2017-2022
Table 37. By Region - Asia Opioid Induced Constipation (OIC) Drugs Sales, (K Pcs), 2023-2028
Table 38. By Country - South America Opioid Induced Constipation (OIC) Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Opioid Induced Constipation (OIC) Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Opioid Induced Constipation (OIC) Drugs Sales, (K Pcs), 2017-2022
Table 41. By Country - South America Opioid Induced Constipation (OIC) Drugs Sales, (K Pcs), 2023-2028
Table 42. By Country - Middle East & Africa Opioid Induced Constipation (OIC) Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Opioid Induced Constipation (OIC) Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales, (K Pcs), 2017-2022
Table 45. By Country - Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales, (K Pcs), 2023-2028
Table 46. Ironwood Pharmaceuticals Inc Corporate Summary
Table 47. Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Product Offerings
Table 48. Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 49. Daiichi Sankyo Co Ltd Corporate Summary
Table 50. Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Product Offerings
Table 51. Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 52. Pfizer Corporate Summary
Table 53. Pfizer Opioid Induced Constipation (OIC) Drugs Product Offerings
Table 54. Pfizer Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 55. Progenics Pharmaceuticals Inc Corporate Summary
Table 56. Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Product Offerings
Table 57. Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 58. Shionogi & Co., Ltd Corporate Summary
Table 59. Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Product Offerings
Table 60. Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 61. Allergan Plc Corporate Summary
Table 62. Allergan Plc Opioid Induced Constipation (OIC) Drugs Product Offerings
Table 63. Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 64. Nektar Therapeutics Corporate Summary
Table 65. Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Product Offerings
Table 66. Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 67. Purdue Pharma Corporate Summary
Table 68. Purdue Pharma Opioid Induced Constipation (OIC) Drugs Product Offerings
Table 69. Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 70. S.L.A. Pharma AG Corporate Summary
Table 71. S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Product Offerings
Table 72. S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 73. Mundipharma International Limited Corporate Summary
Table 74. Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Product Offerings
Table 75. Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 76. Ono Pharmaceutical Co., Ltd Corporate Summary
Table 77. Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Product Offerings
Table 78. Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 79. Takeda Pharmaceutical Company Limited Corporate Summary
Table 80. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Product Offerings
Table 81. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 82. Theravance Biopharma Inc Corporate Summary
Table 83. Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Product Offerings
Table 84. Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 85. Bausch Health Corporate Summary
Table 86. Bausch Health Opioid Induced Constipation (OIC) Drugs Product Offerings
Table 87. Bausch Health Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 88. Cosmo Pharmaceuticals SA Corporate Summary
Table 89. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Product Offerings
Table 90. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 91. Daewoong Pharmaceutical Corporate Summary
Table 92. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Product Offerings
Table 93. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 94. C.B. Fleet Company Corporate Summary
Table 95. C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Product Offerings
Table 96. C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 97. Sucampo Pharmaceuticals Corporate Summary
Table 98. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Product Offerings
Table 99. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 100. Opioid Induced Constipation (OIC) Drugs Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2020-2022 (K Pcs)
Table 101. Global Opioid Induced Constipation (OIC) Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 102. Global Opioid Induced Constipation (OIC) Drugs Production by Region, 2017-2022 (K Pcs)
Table 103. Global Opioid Induced Constipation (OIC) Drugs Production by Region, 2023-2028 (K Pcs)
Table 104. Opioid Induced Constipation (OIC) Drugs Market Opportunities & Trends in Global Market
Table 105. Opioid Induced Constipation (OIC) Drugs Market Drivers in Global Market
Table 106. Opioid Induced Constipation (OIC) Drugs Market Restraints in Global Market
Table 107. Opioid Induced Constipation (OIC) Drugs Raw Materials
Table 108. Opioid Induced Constipation (OIC) Drugs Raw Materials Suppliers in Global Market
Table 109. Typical Opioid Induced Constipation (OIC) Drugs Downstream
Table 110. Opioid Induced Constipation (OIC) Drugs Downstream Clients in Global Market
Table 111. Opioid Induced Constipation (OIC) Drugs Distributors and Sales Agents in Global Market

List of Figures
Figure 1. Opioid Induced Constipation (OIC) Drugs Segment by Type
Figure 2. Opioid Induced Constipation (OIC) Drugs Segment by Application
Figure 3. Global Opioid Induced Constipation (OIC) Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Opioid Induced Constipation (OIC) Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Opioid Induced Constipation (OIC) Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Opioid Induced Constipation (OIC) Drugs Sales in Global Market: 2017-2028 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Opioid Induced Constipation (OIC) Drugs Revenue in 2021
Figure 9. By Type - Global Opioid Induced Constipation (OIC) Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Opioid Induced Constipation (OIC) Drugs Price (USD/Pcs), 2017-2028
Figure 12. By Application - Global Opioid Induced Constipation (OIC) Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Opioid Induced Constipation (OIC) Drugs Price (USD/Pcs), 2017-2028
Figure 15. By Region - Global Opioid Induced Constipation (OIC) Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Opioid Induced Constipation (OIC) Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Opioid Induced Constipation (OIC) Drugs Sales Market Share, 2017-2028
Figure 19. US Opioid Induced Constipation (OIC) Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Opioid Induced Constipation (OIC) Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Opioid Induced Constipation (OIC) Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Opioid Induced Constipation (OIC) Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share, 2017-2028
Figure 24. Germany Opioid Induced Constipation (OIC) Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Opioid Induced Constipation (OIC) Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Opioid Induced Constipation (OIC) Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Opioid Induced Constipation (OIC) Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Opioid Induced Constipation (OIC) Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Opioid Induced Constipation (OIC) Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Opioid Induced Constipation (OIC) Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Opioid Induced Constipation (OIC) Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Opioid Induced Constipation (OIC) Drugs Sales Market Share, 2017-2028
Figure 33. China Opioid Induced Constipation (OIC) Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Opioid Induced Constipation (OIC) Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Opioid Induced Constipation (OIC) Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Opioid Induced Constipation (OIC) Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Opioid Induced Constipation (OIC) Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Opioid Induced Constipation (OIC) Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Opioid Induced Constipation (OIC) Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Opioid Induced Constipation (OIC) Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Opioid Induced Constipation (OIC) Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Opioid Induced Constipation (OIC) Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Opioid Induced Constipation (OIC) Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Opioid Induced Constipation (OIC) Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Opioid Induced Constipation (OIC) Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Opioid Induced Constipation (OIC) Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Opioid Induced Constipation (OIC) Drugs Production Capacity (K Pcs), 2017-2028
Figure 49. The Percentage of Production Opioid Induced Constipation (OIC) Drugs by Region, 2021 VS 2028
Figure 50. Opioid Induced Constipation (OIC) Drugs Industry Value Chain
Figure 51. Marketing Channels

Report Title: Opioid Induced Constipation (OIC) Drugs Market - Global Outlook and Forecast 2022-2028


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

Global Retinal Surgery Devices Market (By Device Segment, Application, Regional Analysis), Impact of COVID-19, Company Profiles, Major Deals, Strategy and Recent Developments – Forecast to 2027

Global Retinal Surgery Devices Market (By Device Segment, Application, Regional Analysis), Impact of COVID-19, Company Profiles, Major Deals, Strategy and Recent Developments – Forecast to 2027

Global Point of Care Testing (POCT) Market (By Diagnostics Segment, Mode, Platform, End Users, Region), Impact of COVID-19, Recent Developments, Company Profiles - Forecast to 2028

Global Point of Care Testing (POCT) Market (By Diagnostics Segment, Mode, Platform, End Users, Region), Impact of COVID-19, Recent Developments, Company Profiles - Forecast to 2028

Animal Wound Care Market by Product (Surgical (Sutures & Staplers, Glues), Advanced (Hydrocolloid, Hydrogel Dressings), Traditional (Tape, Dressings, Bandages), Animal Type (Cats, Dogs, Horse, Pigs), End User (Hospital, Clinics) - Global Forecast to 2027

Animal Wound Care Market by Product (Surgical (Sutures & Staplers, Glues), Advanced (Hydrocolloid, Hydrogel Dressings), Traditional (Tape, Dressings, Bandages), Animal Type (Cats, Dogs, Horse, Pigs), End User (Hospital, Clinics) - Global Forecast to 2027

Veterinary Ultrasound Market by Type (2D, 3D/4D, Doppler), Product (Portable Scanners), Technology (Contrast, Digital), Animal Type (Small, Large), Application (Gynecology, Cardiology, Orthopedics), End User (Clinics, Hospitals) - Global Forecast to 2027

Veterinary Ultrasound Market by Type (2D, 3D/4D, Doppler), Product (Portable Scanners), Technology (Contrast, Digital), Animal Type (Small, Large), Application (Gynecology, Cardiology, Orthopedics), End User (Clinics, Hospitals) - Global Forecast to 2027

Laboratory Animal Models, 3D Cultures and Organoids: Global Markets

Laboratory Animal Models, 3D Cultures and Organoids: Global Markets

Neuromodulation Market by Type (Internal (Deep Brain Stimulation, Vagus Nerve Stimulation), External (Transcranial Magnetic Stimulation)), Application (Parkinson's Disease, Depression, Urine incontinence, Epilepsy, Obesity) - Global Forecast to 2027

Neuromodulation Market by Type (Internal (Deep Brain Stimulation, Vagus Nerve Stimulation), External (Transcranial Magnetic Stimulation)), Application (Parkinson's Disease, Depression, Urine incontinence, Epilepsy, Obesity) - Global Forecast to 2027